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Abstract
Background: There is a well documented causal link between autonomic imbalance and cardiac elec-
trical instability. However, the mechanisms underlying the antiarrhythmic effect of vagal stimulation 
are poorly understood. The vagal antiarrhythmic effect might be modulated by a decrease in heart rate. 
Methods: The proximal anterior interventricular artery was occluded in 16 pigs by clamping under 
general anaesthesia. Group 1: heart rates remained spontaneous (n = 6; 12 occlusions); Group 2: heart 
rates were fixed at 190 bpm with atrial electrical stimulation (n = 10; 20 occlusions). Each pig received 
two occlusions, 30 min apart, one without and one with vagal stimulation (10 Hz, 2 ms, 5–20 mA). 
The antiarrhythmic effect of vagal activation was defined as the time to the appearance of ventricular 
fibrillation (VF) after occlusion.
Results: In Group 1, vagal stimulation triggered a significant decrease in basal heart rate (132 ± 4 vs. 
110 ± 17 bpm, p < 0.05), and  delayed the time to VF after coronary occlusion (1102 ± 85 vs. 925 ±  
± 41 s, p < 0.05). In Group 2, vagal stimulation did not modify the time to VF (103 ± 39 vs. 91 ± 20 s).  
Analyses revealed that heart rate and the time to VF were positively linearly related.
Conclusions: Maintaining a constant heart rate with atrial electrical stimulation in pigs prevented 
vagal stimulation from modifying the time to VF after acute coronary occlusion. (Cardiol J 2018; 25, 
6: 709–713)
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Introduction
Acute myocardial ischemia caused by coronary 
occlusion is at the root of malignant ventricular 
arrhythmias [1]. Several animal models have dem-
onstrated that increasing vagal tone by electrically 
stimulating the vagal nerve reduced incidence of 
ventricular arrhythmias and delayed their appear-
ance [2–5]. The mechanisms underlying the anti-
arrhythmic effect of vagal stimulation are poorly 
understood [6]. 
Apparently, the protective effect of vagal 
stimulation is greater when sympathetic tone is 
high, due to marked antagonism [7–9]. However, 
it is controversial as to whether vagal stimulation 
acts directly through its neuromediator, acetylcho-
line. During the subsidence of acute myocardial 
ischemia in the cat, both before and after vagotomy, 
tissue acetylcholine levels were increased in the 
ischemic zone. This elevation in acetylcholine 
was due to a modification in intracellular calcium 
movements [10]. Cholinergic activation diminished 
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electric instability by reducing heterogeneity of re-
fractory periods in ventricular myocytes. However, 
vagal activation could also maintain the density of 
Connexin-43 intracellular junction proteins [4], 
which favoured normal propagation of cardiac 
influx. These studies have provided a better un-
derstanding of the protective mechanism of vagal 
stimulation. Nevertheless, few data have confirmed 
that vagal stimulation has an antiarrhythmic effect 
independent of its negative chronotropic effect.
The aims of this study were: 1) to study the ef-
fect of vagal stimulation on the time to appearance 
of ventricular fibrillation (VF) after acute coronary 
occlusion; and 2) to determine, under acute ischae-
mic conditions, the role of the heart rate (HR) in 
the antiarrhythmic effect of vagal activation.
Methods
Domestic pigs (n = 16) of both genders, 
2 to 3 months of age, that weighed between 20 and 
25 kg were studied. After general anaesthesia, 
mechanical ventilation with a tracheostomy and 
a sternotomy was performed, this was followed 
by a pericardiectomy. After dissection, both right 
and left cervical vagal nerves were identified, then 
connected to a stimulator (S1 Hugo Sachs, Freiburg 
im Brisgau, Germany) with metal clips. An electro-
drive probe was linked to another stimulator (S1 
Hugo Sachs, Freiburg im Brisgau, Germany) and 
placed in the right atrium, via the jugular vein. 
Electrocardiogram (ECG), arterial blood pressure, 
and CO2 concentration in exhaled expiratory gas 
were continuously recorded. 
Each animal underwent two successive proxi-
mal interventricular artery occlusions by clamping. 
The two occlusions were separated by 30-min 
intervals. Vagal stimulation was associated with 
only one of the two occlusions. Therefore, each 
animal served as its own control. The animals were 
assigned to one of two treatment groups. Group 1 
(6 animals) maintained a spontaneous HR. When 
the coronary occlusion was combined with vagal 
stimulation (10 Hz, 2 ms, 5–20 mA), the stimula-
tion began 10 min before the occlusion, and was 
continued throughout the occlusion. Of 6 animals 
in this group, 3 received coronary occlusion with 
vagal stimulation, followed by occlusion without 
vagal stimulation; the other 3 animals received the 
reverse sequence.
In Group 2 (10 animals), the ventricular con-
traction rate was controlled by atrial electrical 
stimulation. Electrical stimulation was set at a fixed 
frequency of 190 bpm; it began 10 min before oc-
clusion, and it continued throughout the occlusion. 
Again, each animal received two occlusions, one 
without vagal stimulation, and the other combined 
with vagal stimulation (10 Hz, 2 ms, 5–20 mA). 
Vagal stimulation had begun 10 min before and con-
tinued throughout the occlusion. Of the 10 animals 
in this group, 5 received a coronary occlusion with 
vagal stimulation, followed by occlusion without 
vagal stimulation; the other 5 animals received the 
reverse sequence.
The time to the appearance of spontaneous 
ventricular fibrillation (TaVF) after ischemia was 
noted during each experiment. As soon as VF was 
triggered, the occlusion was stopped, and external 
electric shock was administered to restore sinus 
rhythm. 
Statistical analysis
Mean values were compared between groups 
with the Student t-test. The Pearson coefficient 
was used to evaluate correlations. Values are ex-
pressed as the mean ± standard deviation. A value 
of p < 0.05 was considered significant.
Results
In Group 1, vagal stimulation triggered 
a significant increase in the interval between the 
P and R waves on the ECG (PR-interval; 100 ± 5 vs. 
136 ± 12 ms, p < 0.05) and a decrease in sinus rhythm 
(132 ± 4 vs. 110 ± 17 bpm, p < 0.05). After 10 min 
of stimulation,  prolongation of the PR-interval was 
less marked, but remained significant. After vagal 
stimulation, the mean arterial pressure remained 
unchanged (93 ± 16 vs. 83 ± 18 mmHg). After 
coronary occlusion, TaVF was not significantly 
different between occlusions and without vagal 
stimulation. In Group 1, after arterial occlusion, 
TaVF was longer for occlusions combined with 
vagal stimulation than for occlusions without vagal 
stimulation (1102 ± 85 vs. 925 ± 41 s, p < 0.05). 
In Group 2, with a fixed rate of 190 bpm, vagal 
stimulation provoked a significant prolongation of 
time between atrial stimulation artefact and QRS 
wave on the ECG (127 ± 5 vs. 103 ± 6 ms, p < 0.05). 
Additionally, the mean arterial pressure tended to 
be higher during vagal stimulation (87 ± 19 vs. 
68 ± 17 mmHg), but this difference was not sig-
nificant (NS). However, after coronary occlusion, 
TaVFs were not significantly different between 
occlusions with or without vagal stimulation (90 
± 21 vs. 103 ± 39 s, NS; Fig. 1). 
The pigs in Group 1 had lower HRs (121 ± 19 
vs. 191 ± 3 bpm, p < 0.05) and displayed longer 
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basal HR and an increase in the atrioventricular 
conduction time was observed. One explanation 
for differences between studies could be that in-
terspecies variations in coronary anatomy played 
a role in the effects measured. For example, in ani-
mals with a developed collateral circulation, vagal 
stimulation could have a protective effect, because 
it causes vasodilation [14, 15]. This anatomy could 
account for an effect independent of HR in dogs, 
which was not found in pigs [3]. In addition, the 
present coronary occlusions were quite proximal, 
near the ostia of the artery in our model, and the 
location was different in other studies. Finally, it 
has been suggested that vagal nerve stimulation 
exerts anti-arrhythmogenic effects by preventing 
the loss of phosphorylated Connexin-43 during an 
acute myocardial infarction [4]. Indeed, in aged 
rats, loss of antiarrhythmic effect of vagal nerve 
stimulation was associated with reduced expres-
sion of Connexin-43 protein. 
Surprisingly, previous studies that suggested 
that vagal stimulation effect was independent of 
HR did not directly compare experiments with 
a fixed HR to experiments with a variable HR. Ando 
et al. [4] described a model, where vagal stimula-
tion was applied before ischemia was produced. 
That method provided results similar to the re-
sults obtained herein when vagal stimulation was 
performed during myocardial ischemia. Those 
data also suggested that establishing a low HR 
prior to triggering myocardial ischemia provided 
a protective effect. However, their study did not 
include a group of animals that received a fixed 
frequency stimulation to maintain a constant HR. 
Rosentrauckh et al. [6] studied cats that experi-
enced total blockage of vagal activation with the 
administration of pertussis toxin and atropine. The 
harmful effect of vagal tone suppression was noted, 
independent of the frequency, but the authors did 
not demonstrate that vagal stimulation at a fixed 
frequency had a protective effect. Nevertheless, 
interpretation of results from the present study was 
reinforced by their results, because they indicated 
that animals that experienced VF had higher HRs 
than animals that did not experience VF. Kent et al. 
[2] studied VF threshold in dogs after vagal stimu-
lation, without myocardial ischemia. They noted 
that the antiarrhythmic effect of vagal stimulation 
persisted at a fixed HR.
Some studies that used pharmacologic meth-
ods for vagal stimulation did not report an antiar-
rhythmic effect. In the study of Meesmann et al. 
[16], a cholinergic agonist injected retrogradely 
into the coronary sinus or administered systemi-
Figure 1. Survival curves according to the Kaplan-Meier 
estimation show the fraction of each group of pigs that 
remained without ventricular fibrillation (VF) at different 
time points after a coronary occlusion (VS — vagal 
stimulation; w/o VS — without vagal stimulation.
TaVFs (625 ± 415 vs. 98 ± 31 s, p < 0.05) than the 
animals in Group 2 (Table 1). When the animals in 
Groups 1 and 2 were combined, a negative correla-
tion was found between the HR, measured within 
a 3-min period prior to ventricular fibrillation (VF), 
and TaVF. This correlation was strongest, when 
only the first occlusion periods were included in 
linear regression analysis (Fig. 2).
Discussion
The present findings suggest that, when rapid 
HR was fixed with atrial electrical stimulation, 
vagal stimulation did not modify the time to ap-
pearance of VF after occlusion of a coronary artery. 
The model herein indicated that HR was the major 
determining factor for electrical stability during 
an acute event that caused myocardial ischemia. 
This result was consistent with other studies 
which showed that medications that slowed HR, 
like beta-blockers [11], calcium channel inhibitors 
[12], or ivabradine [13], had favourable, antiar-
rhythmic effects.
In contrast to previous studies [2–4, 6, 7], 
a protective effect following rapid fixed frequency 
vagal stimulation by atrial stimulation was not 
found. However, the stimulation parameters ap-
plied in the present model were similar to those 
used in other studies [2–4, 6, 7]. Consistent with 
previous studies, a significant reduction in the 
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cally did not modify the incidence of ventricular 
tachycardia in dogs.
The study by Inagaki et al. [17] stressed the 
importance of bradycardia in the antiarrhythmic ac-
tion of vagal stimulation. A vagal nerve stimulation 
technique via an intravascular approach in dogs was 
used. They reported a reduction in spontaneous 
ventricular arrhythmia incidents after acute myo-
cardial ischemia. However, that protective effect 
disappeared when the atrium was stimulated at 
a fixed frequency of 170 bpm.
Limitations of the study
There were three major limitations in this 
study. First, the appropriateness of the present ex-
perimental model could be debated. It was chosen 
to approximate human clinical conditions. Com-
pared to a mouse or rat, pig physiology is closer 
to human physiology. For example, pigs resemble 
humans in HR (100 to 150 bpm at rest in pigs and 
man vs. 500 bpm in mouse) and coronary anatomy 
(epicardial-like in pigs and man vs. endocardial-like 
in rats) [18]. In animals with developed collateral 
vessels, mean blood flow can be maintained in the 
ischemic zone. Dogs maintainan equivalent of 15% 
of flow observed before coronary occlusion. This 
value is 6% in rats, but in pigs it is less than 1% 
[18]. Moreover, the use of an animal model made 
it possible to take the complexity of the autonomic 
nervous system into account [19]. The second limi-
tation was that there was no measurement of the 
link between HR and coronary arterial vasomotion. 
The vasodilatation of vagal arteries could explain 
the vagal antiarrhythmic effect. It has been shown 
that vagal action in the presence of muscarinic and 
beta-adrenergic blockade significantly reduced the 
Figure 2. Correlation between the time to the appearance of ventricular fibrillation (VF) after occlusion and the mean 
heart rate (HR), measured within 3 min prior to VF, for all animals (Groups 1 and 2). A. Correlation without taking the 
first occlusion into account (correlation coefficient: 0.89); B. Correlation that included both occlusions for each animal 
(correlation coefficient: 0.67).
Table 1. Time to the appearance of ventricular fibrillation (VF) after coronary occlusion (TaVF) for 
groups with (wVS) or without vagal stimulation (w/o VS)
Mean HR 3 min before VF [bpm] Mean TaVF [s]
Group 1 VS (n = 6) 110 ± 17 664 ± 484
Group 1 w/o VS (n = 6) 132 ± 14 586 ± 375
Group 1 total (n = 12) 121 ± 19 625 ± 415
Group 2 VS (n = 10) 192 ± 4 91 ± 20
Group 2 w/o VS (n = 10) 190 103 ± 39
Group 2 total (n = 20) 191 ± 3 98 ± 31
Data are shown as mean ± standard deviation; HR — heart rate
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resistance of coronary arties, due to facilitation of 
the release of vasoactive intestinal peptide [20]. 
The third limitation was that the time to the ap-
pearance of VF after coronary occlusion was not 
the best criterion for cardiac electrical instability. 
However, this measurement was considered to be 
closer to criterion used in human clinical scenarios 
rather than artificially obtained criteria, such as the 
fibrillation threshold.
Conclusions
This study showed that, when HR was main-
tained at a constant rate with atrial electrical stimu-
lation in pigs, vagal stimulation did not modify the 
time to appearance of VF. The negative correlation 
between HR and the time to appearance of VF sug-
gests that HR played a determining role in cardiac 
electrical stability after arterial occlusion. These 
results reinforce the need to prescribe brady-
cardia-inducing medications in the acute phase of 
myocardial infarction. Finally, these findings call 
for future studies on mechanisms that underlie 
antiarrhythmic actions of medicinal substances. 
Moreover, non-pharmacological approaches for 
vagal stimulation are rapidly developing, and 
validation of these approaches should include anti-
arrhythmic measurements. 
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